Nazih; Abdesslame

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nazih; Abdesslame.The latest application filed is for "noxel oxime derivatives of 3, 5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same".

Company Profile

0.5.5

Nazih; Abdesslame - Marseilles N/A FR
Nazih; Abdesslame - Marseille FR
Nazih, Abdesslame - Strasbourg FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Oxime derivatives of 3,5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same Grant 9,115,059 - Drouot , et al. August 25, 2	2015-08-25
Noxel Oxime Derivatives Of 3, 5-seco-4-nor-cholestane, Pharmaceutical Compositions Containing Same, And Method For Preparing Same App 20110275680 - Drouot; Cyrille ; et al.	2011-11-10
Complexes for transferring substances of interest into a cell App 20050261214 - Braun, Serge ; et al.	2005-11-24
Glycerolipid compounds useful for the transfer of an active substance into a target cell Grant 6,743,781 - Bischoff , et al. June 1, 2	2004-06-01
Lipid compounds and compositions containing them which can be used for the transfer of at least one active substance, in particular a polynucleotide, into a target cell and use in gene therapy App 20020151070 - Bischoff, Rainer ; et al.	2002-10-17
Novel lipid complexes for transferring at least one therapeutically active substance, in particular a polynucleotide, into a target cell, and use in gene therapy App 20020025920 - Bischoff, Rainer ; et al.	2002-02-28
Glycerolipid compounds useful for the transfer of an active substance into a target cell App 20010036927 - Bischoff, Rainer ; et al.	2001-11-01
Lipid complexes for transferring at least a therapeutically active substance, in particular a polynucleotide into a target cell and use in gene therapy Grant 6,291,423 - Bischoff , et al. September 18, 2	2001-09-18
Glycerolipidic compounds used for the transfer of an active substance into a target cell Grant 6,218,370 - Bischoff , et al. April 17, 2	2001-04-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.